Prognostic value of a history of hypertension in 11483 patients with acute myocardial infarction treated with thrombolysis

被引:54
作者
Fresco, C
Avanzini, F
Bosi, S
Franzosi, MG
Maggioni, AP
Santoro, L
Bellanti, G
机构
[1] OC UDINE,IST CARDIOL,UDINE,ITALY
[2] IST RIC FARMACOL MARIO NEGRI,MILAN,ITALY
[3] OC RAVENNA,IST CARDIOL,RAVENNA,ITALY
关键词
arterial hypertension; acute myocardial infarction; prognostic factor;
D O I
10.1097/00004872-199606000-00010
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective To assess the prognostic value of a history of hypertension in patients with acute myocardial infarction (AMI) treated with thrombolysis. Design Retrospective adjusted analysis of outcome data of patients with AMI randomly allocated to treatment in a controlled study of alteplase versus streptokinase and heparin versus no heparin. Setting A highly representative sample (about 90%) of Italian Coronary Care Units. Patients Patients with (n = 3306) and without (n = 7406) a history of treated hypertension. Main outcome measures Morbidity and mortality during hospital stay and the next 6 months. Results Patients with a history of hypertension had a significantly higher mortality, both in hospital and during the next 6 months. The difference persisted also after a multivariate analysis including all major prognostic factors for in-hospital and 6-month mortality, respectively. Left ventricular failure and recurrent ischaemic events (angina and re-infarction) were also significantly more frequent in hypertensives both during their hospital stay and during follow-up study. Conclusions A history of hypertension is a negative independent prognostic factor after acute myocardial infarction treated with thrombolysis.
引用
收藏
页码:743 / 750
页数:8
相关论文
共 33 条
  • [1] [Anonymous], 1990, Lancet, V336, P65
  • [2] BIGGER JT, 1978, AM J CARDIOL, V42, P202, DOI 10.1016/0002-9149(78)90901-3
  • [3] CLEEMPOEL H, 1988, BRIT HEART J, V60, P98
  • [4] BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT
    COLLINS, R
    PETO, R
    MACMAHON, S
    HEBERT, P
    FIEBACH, NH
    EBERLEIN, KA
    GODWIN, J
    QIZILBASH, N
    TAYLOR, JO
    HENNEKENS, CH
    [J]. LANCET, 1990, 335 (8693) : 827 - 838
  • [5] CRUICKSHANK JM, 1987, LANCET, V1, P581
  • [6] RELATION OF LOW DIASTOLIC BLOOD-PRESSURE TO CORONARY HEART-DISEASE DEATH IN PRESENCE OF MYOCARDIAL-INFARCTION - THE FRAMINGHAM-STUDY
    DAGOSTINO, RB
    BELANGER, AJ
    KANNEL, WB
    CRUICKSHANK, JM
    [J]. BRITISH MEDICAL JOURNAL, 1991, 303 (6799) : 385 - 389
  • [7] De Martini M, 1990, G Ital Cardiol, V20, P215
  • [8] THE J-CURVE PHENOMENON AND THE TREATMENT OF HYPERTENSION - IS THERE A POINT BEYOND WHICH PRESSURE REDUCTION IS DANGEROUS
    FARNETT, L
    MULROW, CD
    LINN, WD
    LUCEY, CR
    TULEY, MR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (04): : 489 - 495
  • [9] GRECO R, 1984, Giornale Italiano di Cardiologia, V14, P1015
  • [10] RECENT-EVIDENCE ON DRUG-THERAPY OF MILD TO MODERATE HYPERTENSION AND DECREASED RISK OF CORONARY HEART-DISEASE
    HEBERT, PR
    MOSER, M
    MAYER, J
    Glynn, RJ
    HENNEKENS, CH
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (05) : 578 - 581